Whan In Pharm Co.,Ltd.

₩10,760As of Sun 8 Nov 2026, 12:00 UTC
KRX:016580Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (1.14%)
Div yield 2.79%
ROE 5.08%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.12
PE TTM 9.191
TSR TTM (3.11%)
Mkt cap ₩198.9B
ROIC 4.96%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩13,397
24.50%
(96.64%)
Hold 12|6|10|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
150.74
147.41
150.14
154.24
19.51%
11.49%
8.60%
14.26%
Revenue₩B
10.71
10.57
10.60
10.32
2.25%
(1.88%)
(2.78%)
(3.06%)
Peers (US$146.6M)
Cap (US$)
PE
144.0M
4.986x
138.1M
9.932x
126.0M
3.284x
Capital
TTM
5Y
10Y
Leveragex
7.882
0.364
0.306
EBIT/Intx
1.044
0.448
0.386
Own earn%
52.59
(5.88)
(10.43)
Sh yield%
37.45
52.84
51.43
Owners
Insiders/Inst%
5.90
23.90
Short interest%
0.59
SBC / revenue%
4.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
2–9
$1 testx
−0.3
Incr. ROIC%
12